- The company is getting ever more entrenched in the healthcare sector, growing with their customers, adding new ones, and adding new solutions and through M&A.
- Adjusted EBITDA growing much faster than revenues, testifying to operational leverage from automation and machine learning.
- The shares are not a bargain, but then again there are few bargains in this sector and they’re not excessively expensive either.
- Looking for a portfolio of ideas like this one? Members of SHU Growth Portfolio get exclusive access to our model portfolio. Learn More »